SIS
ADMA icon

Sound Income Strategies’s ADMA Biologics ADMA Stock Holding History

Sound Income Strategies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-471
Closed -$4.29K – 510
2026
Q1 		$4.29K Sell
471
-539
-53% -$8.51K ﹤0.01% 1896
2025
Q4 		$17.5K Buy
+1,010
New +$17K ﹤0.01% 1206

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sound Income Strategies's ADMA Position: Q2 2026 in Review

Sound Income Strategies sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 471 shares — an estimated $4.29K sold.

Sound Income Strategies first reported a position in ADMA in Q4 2025 and held it in 2 quarters. The position peaked at $17.5K in Q4 2025. 241 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Sound Income Strategies reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 471 ADMA Biologics shares in Q2 2026, an estimated $4.29K.
  • Sound Income Strategies first reported a position in ADMA Biologics in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's ADMA Biologics position peaked at $17.5K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.